These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7213523)

  • 21. A study with cumulative doses of formoterol and salbutamol in children with asthma.
    Foucard T; Lönnerholm G
    Eur Respir J; 1991 Nov; 4(10):1174-7. PubMed ID: 1687130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral doxophylline in patients with chronic obstructive pulmonary disease.
    Villani F; De Maria P; Ronchi E; Galimberti M
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of bronchodilator effects of salbutamol and theophylline (author's transl)].
    Racineux JL; Troussier J; Turcant A; Tuchais E; Allain P
    Bull Eur Physiopathol Respir; 1981; 17(5):799-806. PubMed ID: 7296082
    [No Abstract]   [Full Text] [Related]  

  • 24. The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: a pilot study.
    Cazzola M; Gabriella Matera M
    Respir Med; 2007 May; 101(5):957-62. PubMed ID: 17056241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled formoterol during one year in asthma: a comparison with salbutamol.
    Arvidsson P; Larsson S; Löfdahl CG; Melander B; Svedmyr N; Wåhlander L
    Eur Respir J; 1991 Nov; 4(10):1168-73. PubMed ID: 1687129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Responses to large doses of salbutamol and theophylline in patients with chronic obstructive pulmonary disease.
    Filuk RB; Easton PA; Anthonisen NR
    Am Rev Respir Dis; 1985 Oct; 132(4):871-4. PubMed ID: 4051322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the bronchodilating efficacies of a novel salbutamol metered dose powder inhaler and a pressurised metered dose aerosol with a spacer.
    Seppälä OP; Kari E; Elo J; Löyttyniemi E; Kunkel G
    Arzneimittelforschung; 1998 Sep; 48(9):919-23. PubMed ID: 9793619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of the combination of theophylline and beta 2 agonists by oral route on pulmonary function of patients with chronic obstructive lung disease].
    Carvalho-Pinto RM; Terra Filho M; Cukier A; Santos SR; Verrastro C; Teixeira LR; Vargas FS
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):166-9. PubMed ID: 1843713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of oral theophylline on resting energy expenditure in normal volunteers.
    Dash A; Agrawal A; Venkat N; Moxham J; Ponte J
    Thorax; 1994 Nov; 49(11):1116-20. PubMed ID: 7831627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the bronchodilator properties of Ro 31-6930, a novel potassium channel opener, in the guinea-pig.
    Paciorek PM; Cowlrick IS; Perkins RS; Taylor JC; Wilkinson GF; Waterfall JF
    Br J Pharmacol; 1990 Jun; 100(2):289-94. PubMed ID: 2379034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose inhaled versus intravenous salbutamol combined with theophylline in severe acute asthma. Swedish Society of Chest Medicine.
    Eur Respir J; 1990 Feb; 3(2):163-70. PubMed ID: 2178964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects.
    Bennett JA; Tattersfield AE
    Thorax; 1997 May; 52(5):458-64. PubMed ID: 9176539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A comparison of bronchodilating drugs in the treatment of stable COPD].
    Nishimura K; Koyama H; Izumi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):835-43. PubMed ID: 1385837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous infusion of salbutamol in the treatment of asthma.
    Spiro SG; Johnson AJ
    Br J Clin Pharmacol; 1975 Dec; 2(6):503-8. PubMed ID: 1234014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A method for bioassay of potency and effectiveness of inhaled bronchodilators in normal subjects.
    Foster RW; Atanga GK; Carpenter JR; Evans DE; Rakshi K; Small RC
    Br J Clin Pharmacol; 1991 Apr; 31(4):445-55. PubMed ID: 2049254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.
    Britton MG; Earnshaw JS; Palmer JB
    Eur Respir J; 1992 Oct; 5(9):1062-7. PubMed ID: 1426215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salbutamol plus beclomethasone dipropionate versus theophylline for the prevention of methacholine-induced bronchospasm in patients with chronic bronchitis.
    Arossa W; Spinaci S; Testi R
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):565-8. PubMed ID: 4066080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and tolerability of high-dose formoterol (via Aerolizer) and salbutamol in patients with chronic obstructive pulmonary disease.
    Rosenkranz B; Rouzier R; Kruse M; Dobson C; Ayre G; Horowitz A; Fitoussi S
    Respir Med; 2006 Apr; 100(4):666-72. PubMed ID: 16303295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Salbutamol in Mixed Obstructive and Restrictive Pattern Spirometry.
    Tuladhar LR; Tamrakar Tuladhar ET
    Kathmandu Univ Med J (KUMJ); 2017 Oct.-Dec.; 15(60):279-283. PubMed ID: 30580341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral fenoterol versus sustained release theophylline in adult asthmatics.
    Lucena MI; Almagro J; Andrade RJ; Hidalgo Sanchez R; Sanchez de la Cuesta F
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):19-23. PubMed ID: 9021437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.